Vaccine News and Research

Latest Vaccine News and Research

CSL Biotherapies submits Biologics License Application to FDA

Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.S. marketplace. The company's BLA requests that the vaccine be approved to immunize people 18 years of age and older.

3 Apr 2007

Emerging threats demand new approach to disaster preparedness

The SARS epidemic, the South Asian tsunami, Hurricane Katrina, and avian influenza all underline a growing need for preparedness planning that addresses multiple hazards and coordinates all levels of government and society, said a panel of public health experts today at the Pan American Health Organization (PAHO) in Washington, D.C.

3 Apr 2007

Severe dengue infections may go unrecognized in international travelers

Severe cases of a common travelers' infection may not be recognized if doctors rely on the World Health Organization's (WHO) guidelines for identifying it, according to a new study published in the April 15 issue of The Journal of Infectious Diseases, now available online.

3 Apr 2007

New hope for a rabies cure

The appeal, by Rodney Willoughby, M.D., associate professor of pediatrics, appears in the April 2007 issue of Scientific American.

3 Apr 2007

Nanocrystal research for cellulose drug delivery

Maren Roman is taking nanocrystal research to a new level that may lead to a new generation of vaccines and better computer printer ink.

2 Apr 2007

Immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease

Although stem cells hold incredible promise in the fight against certain diseases, in cancer they're anything but helpful. In fact, mounting evidence is showing that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor.

2 Apr 2007

New York progresses HPV vaccine distribution to health providers, school clinics

The New York City Department of Health and Mental Hygiene on Thursday announced that it has distributed 57,810 doses of Merck's human papillomavirus vaccine Gardasil to city health providers, including school-based health clinics, the New York Post reports.

2 Apr 2007

Six centers of excellence for influenza research and surveillance established in U.S.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

2 Apr 2007

PCV7 vaccine reduces frequent ear infections in children

A vaccine has been shown to help reduce the number of infants and toddlers developing frequent ear infections, according to new research from Katherine A. Poehling, M.D., a pediatrician at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center.

2 Apr 2007

Pseudoknots an important step in developing a viral vaccine

How is virus as for example HIV and bird flu able to make the cells within a human body work for the purpose of the virus?

2 Apr 2007

MedImmune licenses reverse genetics technology to sanofi pasteur

MedImmune has announced that it has licensed its proprietary reverse genetics intellectual property to sanofi pasteur, the vaccines business of the sanofi-aventis Group, to support the development and construction of new vaccine strains to produce human seasonal, pre-pandemic and pandemic influenza vaccines.

1 Apr 2007

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.

1 Apr 2007

GlaxoSmithKline files European meningococcal conjugate vaccine

GlaxoSmithKline has announced the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix (diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Neisseria meningitides serogroups A and C).

1 Apr 2007

Study reveals impact of the MMR controversy on parents of children with autism

Researchers have found that the MMR controversy caused parents of children with autism feelings of stress, guilt and frustration. Their study is published in Archives of Disease Childhood.

29 Mar 2007

Immune response to cancer stem cells may dictate cancer's course

Although stem cells hold incredible promise in the fight against certain diseases, in cancer they're anything but helpful. In fact, mounting evidence is showing that a tumor's growth and spread may depend on 'cancer stem cells,' which comprise only a very small subset of the tumor.

27 Mar 2007

Progress towards better access to pandemic influenza vaccines for developing countries

The World Health Organization (WHO) is reporting progress towards ensuring access to pandemic influenza vaccines for developing countries in the event of a pandemic and other vaccine-related aspects of influenza pandemic preparedness.

25 Mar 2007

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

22 Mar 2007

Canada budgets $258 million for human papillomavirus vaccination programs

The Canadian government on Monday announced that it is including about $258 million in the 2007-2008 budget to help pay for provincial human papillomavirus vaccination programs, Toronto's Globe and Mail reports.

22 Mar 2007

Stanford brain tumor vaccine to be tested nationally

When Susan Wright learned that she had a type of fatal, rapidly growing brain cancer at age 46, her doctors at the University of Florida told her she wouldn't live more than 18 months.

22 Mar 2007

Global tuberculosis epidemic has levelled off

The global tuberculosis (TB) epidemic has levelled off for the first time since WHO declared TB a public health emergency in 1993. The Global Tuberculosis Control Report released today by WHO finds that the percentage of the world's population struck by TB peaked in 2004 and then held steady in 2005.

22 Mar 2007